Live from the NIH registry
Studies recruiting near Orlando right now
Top 25 of 934 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
AdventHealth — Altamonte Springs, Florida (12.8 mi)
· Sponsor: Relay Therapeutics, Inc.
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Florida Inst For Clin Res LLC — Orlando, Florida (4.9 mi)
· Sponsor: Novo Nordisk A/S
Improving Mechanics and Confidence in the Hip Hinge
Hip Hinge, Hip and Knee Movement
N/A
Interventional 30 participants sought
University of Central Florida — Orlando, Florida (4.9 mi)
· Sponsor: University of Central Florida
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Orlando, Florida (4.9 mi)
· Sponsor: Axsome Therapeutics, Inc.
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
Neurology Associates, P. A. — Maitland, Florida (10.5 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Orlando, Florida (4.9 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Omega Research DeBary — Orlando, Florida (4.9 mi)
· Sponsor: Crystalys Therapeutics
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Orlando, Florida (4.9 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Florida Eye Clinic — Altamonte Springs, Florida (12.8 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
I.H.S Health LLC-Kissimmee-445 W Oak St — Kissimmee, Florida (12.9 mi)
· Sponsor: Takeda
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
FC Site Partners Miami — Winter Park, Florida (8.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjögren, Sjogren Disease
Phase 1
Interventional 36 participants sought
Cullinan Investigative Site — Orlando, Florida (4.9 mi)
· Sponsor: Cullinan Therapeutics Inc.
Unity Cures Future (UCF) Biobank
Tissue Banking
N/A
Observational 10,000 participants sought
University of Central Florida — Orlando, Florida (4.9 mi)
· Sponsor: University of Central Florida
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Florida Cancer Specialists — Orlando, Florida (4.9 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
West Orange Endocrinology — Ocoee, Florida (14.1 mi)
· Sponsor: Novo Nordisk A/S
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Clinical Site Partners, LLC dba Flourish Research — Winter Park, Florida (8.5 mi)
· Sponsor: Biomea Fusion Inc.
Effect of Resveratrol Supplementation on Exercise Performance and Recovery
Effect of Resveratrol on Performance and Recovery
N/A
Interventional 20 participants sought
University of Central Florida EPIC Lab — Orlando, Florida (4.9 mi)
· Sponsor: University of Central Florida
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 150 participants sought
Accel Research Sites Network — Maitland, Florida (10.5 mi)
· Sponsor: Navigator Medicines, Inc.
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
Healthy, Hepatic Impairment
Phase 1
Interventional 32 participants sought
Orlando Clinical Research Center — Orlando, Florida (4.9 mi)
· Sponsor: Boehringer Ingelheim
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Kissimmee, Florida (12.9 mi)
· Sponsor: Xencor, Inc.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Orlando, Florida (4.9 mi)
· Sponsor: AstraZeneca
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Orlando Health Digestive Health Institute — Orlando, Florida (4.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Advanced/Metastatic Solid Tumors, Colorectal Cancer
Phase 1, Phase 2
Interventional 523 participants sought
Sarah Cannon Research Institute (Lake Nona) — Orlando, Florida (4.9 mi)
· Sponsor: Merus B.V.
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Obesity & Overweight
N/A
Interventional 80 participants sought
University of Central Florida — Orlando, Florida (4.9 mi)
· Sponsor: University of Central Florida
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Orlando, Florida (4.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S